In that study, it was reported that the upregulation of miR-7-5p inhibited cell proliferation, invasion, and migration by targeting CKS2, suggesting that the miR-7-5p/CKS2 axis could serve as a foundation for developing miRNA-targeted therapies in papillary thyroid carcinoma [36]. This evidence concerns the gene CKS2 and differentiated thyroid carcinoma.